NCT07444983 2026-03-03
Rezvilutamide for High-Risk Prostate Cancer After Surgery
Fujian Medical University Union Hospital
Phase NA Not yet recruiting
Clinical Trials
8 trialsNCT06512207 2025-09-09
A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung Cancer
Jinzhou Medical University
Phase NA Recruiting
NCT02346253 2025-04-03
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
Stanford University
Phase NA Active not recruiting
NCT04192812 2020-06-23
PREOPERATIVE GONADOTROPINE-RELEASING HORMONE AGONIST THERAPY BEFORE SURGERY FOR UTERÄ°N FIBROIDS
Alkü Alanya Education and Research Hospital
Phase NA Unknown
NCT03662958 2018-09-10
Comparison of a Novel Leuprolide With Market Leuprolide
Lee's Pharmaceutical Limited
Phase NA Unknown
NCT00004436 2015-03-25
Randomized Study of Hormonal Regulation of Infantile Hemangioma
FDA Office of Orphan Products Development
Phase NA Completed
NCT01344564 2013-03-18
Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide
Urology of Virginia
Phase NA Completed
NCT00056654 2008-09-17
Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
Abbott
Phase NA Completed